Manorama Industries (541974) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
14 Aug, 2026Executive summary
Achieved 39.5% year-over-year revenue growth in Q1 FY2027, surpassing INR 4,000 million in quarterly revenue and EBITDA for the first time, with PAT up 67.6% year-over-year, reflecting strong demand, operational leverage, and a higher value-added product mix.
Expanded global sourcing and manufacturing footprint, including new subsidiaries in Chad and land acquisition in Burkina Faso for Shea processing.
Completed a qualified institutional placement (QIP), raising INR 500 crore in July 2026 to strengthen the balance sheet ahead of major capex cycle.
Maintained a 60:40 export to domestic revenue mix in Q1 FY2027, highlighting robust international demand.
Board approved unaudited standalone and consolidated financial results for Q1 FY27 and scheduled the 21st AGM for September 21, 2026.
Financial highlights
Q1 FY27 revenue: INR 4,040 million (up 39.5% year-over-year); EBITDA: INR 1,062 million (up 42.2% year-over-year, margin 26.3%); PAT: INR 787 million (up 67.6% year-over-year, margin 19.5%).
Standalone revenue from operations for Q1 FY27 was ₹40,395.93 lakhs, with standalone net profit after tax at ₹8,158.59 lakhs.
Consolidated revenue from operations for Q1 FY27 was ₹40,400.60 lakhs, with consolidated net profit after tax at ₹7,865.82 lakhs.
Other income for the quarter was INR 16 crore, mainly from forex gains (INR 13 crore) and FDR interest.
Gross margin typically ranges 45%-50%, with raw material costs around 50% of sales.
Outlook and guidance
Confident in delivering healthy top-line growth for FY2027, supported by capacity ramp-up and debottlenecking.
Utilization guidance for fractionation capacity is 80%-85% for the full year.
New CapEx projects in India and Burkina Faso expected to be operational by Q3 FY2028, with full impact visible in FY2029.
INR 460 crore capex planned over next 2-3 years to expand fractionation, refining, and global integration, with major projects targeting FY28 commissioning.
Annual report and AGM notice, including voting procedures and final dividend eligibility, will be shared in due course.
Latest events from Manorama Industries
- Strong Q2/H1 growth and exports support phased expansion despite margin and cash-flow pressures.541974
Q2 26/27 - Manufacturing growth and capacity investment offset the exit from trading.541974
Q4 18/19 - FY23 growth accelerated as capacity expanded, despite input-cost and execution pressures.541974
Q4 22/23 - Revenue rose 37.8% and PAT 65.6% as expansion targets global specialty-fat demand.541974
Q4 21/22 - FY20 sales rose 84% as a new plant expanded capacity amid pandemic disruption.541974
Q4 19/20 - Revenue advanced, but pandemic pressure cut profit as capacity expansion continued.541974
Q4 20/21 - Revenue up 76.1%, EBITDA up 92.5%, and major CapEx and expansion plans approved.541974
Q4 25/26 - Record Q3 FY25 revenue and profit, strong margins, and global expansion with new subsidiaries.541974
Q3 24/25 - H1 FY26 revenue and profit surged YoY, margins remained strong, and FY26 guidance was upgraded.541974
Q2 25/26